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Abstract  
 
Objectives: To estimate the prevalence of canine diabetes mellitus (DM) in primary-
care clinics in England, to identify risk factors associated with DM and to describe the 
survival of affected dogs. 
 
Methods: Cases of DM were identified within the electronic patient records of 89 
small-animal practices. A nested case-control study identified risk factors for the 
diagnosis of DM using logistic regression models. Cox proportional hazards models 
were used to analyse variables associated with survival. 
 
Results: Four-hundred and thirty-nine canine DM cases were identified, giving an 
apparent prevalence of 0.34% (95% confidence interval 0.31 - 0.37%). Neutered 
males were at an increased risk of diabetes compared to entire males, whereas 
neutering was not associated with DM in females. Compared with crossbred dogs, 
Yorkshire terriers had increased odds, whereas German shepherd dogs and golden 
retrievers had lower odds of DM. Being classified as overweight and having a 
diagnosis of pancreatitis, hyperadrenocorticism or a urinary tract infection were 
positively associated with DM. Older dogs and those diagnosed with pancreatitis had 
a higher hazard of death, whereas insured and neutered dogs had a lower hazard. 
 
Clinical significance: This study provides an objective assessment of canine DM 
using primary-care veterinary practice data and is a valuable benchmark against 
which future epidemiological trends in DM can be assessed and improvements in the 
management of DM in primary-care practice can be judged. 
 
 
 
 
 
  
Introduction 
 
Canine diabetes mellitus (DM) is a complex endocrinopathy that develops as a result 
of the interplay between environmental and genetic factors. Although the 
pathogenesis of the disease varies between individuals, similar clinical signs, 
including polyuria, polydipsia and weight loss, are commonly reported irrespective of 
the underlying aetiology (Catchpole and others 2013). New management strategies 
and therapies for canine DM are currently being developed (Wiedmeyer and DeClue 
2011; Niessen and others 2012; Hess and Drobatz 2013), which may alter the 
outcome of affected animals and subsequently impact on the future epidemiology of 
the disease. Human type 1 DM, a disease with an autoimmune aetiology (Bluestone 
and others 2010), shares some characteristics with canine DM (Catchpole and others 
2008), which may be influenced by environmental factors shared by both species. It is 
possible that an increasing incidence of human type 1 DM (Tuomilehto 2013) may be 
mirrored in the canine population. Recording baseline epidemiological data, such as 
prevalence and median survival times, provides a useful benchmark for observing 
future trends over time and for evaluating the impact of novel interventions or 
changes in underlying risk factors. 
 
Prevalence estimates of canine DM from referral practice and insurance database 
populations range between 0.32% and 1.33% (Guptill and others 2003; Fracassi and 
others 2004; Davison and others 2005). The current prevalence within primary 
practice caseloads in the UK may differ from these existing estimates. 
 
Factors associated with diagnosis of the disease include signalment. DM is generally 
diagnosed in dogs between 5 and 12 years old (Guptill and others 2003; Davison and 
others 2005; Fall and others 2007), although rare cases of familial DM in juvenile 
dogs have been reported (Kramer 1981; Davison and others 2005). Females were at a 
greater risk of DM in some studies (Foster 1975; Doxey and others 1985; Guptill and 
others 2003; Fall and others 2007), although this finding was not observed in a UK 
study (Davison and others 2005). Geographical or temporal variation in neutering 
practices may influence the sex pre-dispositions within a population, although 
associations identified between neutering and DM diagnosis have varied between 
studies. Doxey and others (1985) observed significantly more entire females in the 
diabetic population compared with the general dog population attending a veterinary 
hospital. However, Guptill and others (2003) reported that, although females were 
overall at increased risk of DM compared with males, there was no significant 
difference in risk between neutered and entire females. Conversely, neutered males 
had higher odds of DM than entire males (Guptill and others 2003).  
 
Epidemiological studies have identified breed differences in the susceptibility to DM 
(Foster 1975; Doxey and others 1985; Hess and others 2000a; Guptill and others 
2003; Fracassi and others 2004; Catchpole and others 2005; Fall and others 2007), 
suggesting a genetic component to this complex disease (Catchpole and others 2005). 
Samoyed and poodles are frequently reported to be predisposed breeds (Doxey and 
others 1985; Hess and others 2000a; Guptill and others 2003; Fracassi and others 
2004; Catchpole and others 2005; Fall and others 2007), whereas German shepherd 
dogs and boxers are suggested to have a decreased risk of DM (Guptill and others 
2003; Fracassi and others 2004; Catchpole and others 2005).  
 
Co-morbidities with canine DM are frequent (Hess and others 2000b; Davison and 
others 2005; Hume and others 2006); some of which may contribute to the 
development of the disease. Destruction of insulin-secreting pancreatic beta cells due 
to immune-mediated disease or exocrine pancreatic disease may be part of the 
pathogenesis of canine DM in some cases (Watson and others, 2007). Insulin 
antagonism as a result of pathological (endocrine or iatrogenic) or physiological 
(gestation or dioestrus) processes is also thought to be a component of the 
development of the disorder (Watson and others 2007; Catchpole and others 2008; 
Fall and others 2010). Dogs are thought to be resistant to disease comparable to type-
2 diabetes in humans (Verkest and others 2011). However, reversible insulin 
resistance and greater postprandial blood glucose concentrations were associated with 
canine obesity (German and others 2009; Verkest and others 2012). Two small studies 
reported an association between excess weight and canine DM (Klinkenberg and 
others 2006; Wejdmark and others 2011) but they should be viewed with some 
caution because body condition score was owner-perceived and recorded after DM 
diagnosis. 
 
A winter peak in the diagnosis of both canine diabetes and human type-1 DM has 
been reported (Davison and others 2005; Moltchanova and others 2009), although 
other studies found no seasonal incidence of canine DM (Guptill and others 2003; Fall 
and others 2007).  
 
There are limited published survival data for canine DM. In a population of dogs 
treated for diabetic ketoacidosis (DKA) at a university hospital, 70% survived to 
discharge (Hume and others 2006). In a study of insured dogs in Sweden, the median 
survival time was 57 days after the first insurance claim, with significant differences 
in survival time between breeds (Fall and others 2007). Seventy per cent of diabetic 
dogs referred to a UK veterinary school between 1979 and 1983 were successfully 
stabilised on insulin; 64% of stabilised dogs survived for more than 1 year (Doxey 
and others 1985).   
 
There are wide variations in study populations, methodology and analysis in the 
literature concerning the epidemiology of canine DM. Pet insurance or referral 
populations may be subject to selection bias (Egenvall and others 2009; Bartlett and 
others 2010). Moreover, the generalisability of studies conducted at other times or 
geographical locations may be limited; varying genetic pools or environmental 
influences may result in differing predispositions between countries. On-going 
analyses of large-scale primary practice data using electronic patient records (EPRs) 
would improve understanding of the epidemiology of DM in dogs.  
 
The aims of the current study were to evaluate DM prevalence, risk factors for 
diagnosis and survival in dogs attending primary-care clinics in England. 
 
Materials and methods  
Electronic patient record data were uploaded from veterinary clinics in England, 
between August 2009 and June 2012, as part of the Veterinary Companion Animal 
Surveillance System project (VetCompass 2012). Veterinary surgeons coded clinical 
diagnoses at the time of consultation, by selecting appropriate summary terms from a 
standardised list of VeNom codes (Venom Coding Group 2012). In addition, routinely 
collected demographic data, clinical notes and details of prescribed treatments were 
available for analysis. Data were available for all dogs attending the participating 
clinics during the study period.    
 
Sample size calculations estimated that approximately 200 cases and 400 non-diabetic 
controls would be required to detect an odds ratio (OR) of two, for a variable to which 
10% of controls were exposed in an unmatched case control study (95% significance 
level, 80% power, case-control ratio 1:2) (Epi Info 7 2012). Ethics approval was 
provided by the Royal Veterinary College’s Ethics and Welfare Committee (URN 
2010 1076C). 
  
To identify diabetic cases, the VetCompass database was searched for dogs with 
coded summary diagnoses of “diabetes mellitus” or “diabetic ketoacidosis”. 
Treatment notes were searched for generic and brand names of insulin and oral 
hypoglycaemic agents. Clinical notes were searched for “diab*”, “insul*, “hypergl*” 
and “glucosu*” to allow for spelling errors. Further searches for “DM” or “ketones” 
together with “PTS” or “euth” were performed. Animal identification numbers from 
each search method were aggregated and duplicate records were removed. The case 
definition required at least one of the following criteria: a definitive veterinary 
diagnosis of DM documented in the clinical notes, summary diagnosis or insurance 
claims, prescribed insulin treatment or documented glucosuria and ketonuria (≥2+ on 
urine dipstick). Dogs with a tentative or differential summary diagnosis of DM but 
not otherwise satisfying the above case definition, and dogs receiving insulin to treat 
hyperkalaemia were excluded. 
 
Prevalence estimate 
 
Both pre-existing cases (diagnosed with DM before data collection began) and 
incident cases (newly diagnosed with DM during the data collection period) were 
included in the prevalence estimate. This was calculated by dividing the number of 
DM cases by the total number of dogs attending participating clinics during the study 
period. Standard methods were used to calculate the 95% confidence intervals (95% 
CI) to indicate the precision of the estimate (Kirkwood and Sterne 2003). 
 
Case-control study 
 
A nested case-control study was used to identify risk factors for DM diagnosis by 
comparing the characteristics of the incident DM cases to a sample of non-diabetic 
control dogs. Cases were categorised into four groups based on last recorded age (3.0 
- <8.0 years, 8.0 - <11.0 years, 11.0 - <13.0 years and ≥13.0 years) and were 
frequency matched by age to controls at a 1:2 case-control ratio. A random sequence 
generator (Random.org) was used to select the controls for each age group within the 
population of non-diabetic dogs attending participating practices. The demographic 
data available for each dog included clinic ID, date of birth, VeNom breed term 
(Venom Coding Group 2012), sex, neuter status, bodyweight and insurance status. 
Dog breeds were further classified as purebred or crossbred and whether the breed 
was recognised by the UK Kennel Club (Kennel Club 2012). Breeds with greater than 
ten dogs were evaluated individually, whereas less popular breeds were combined as a 
‘Purebred others’ category. Maximum weights for each animal were calculated from 
all recorded bodyweight entries and additionally categorised. The date of DM 
diagnosis was defined as the date the first confirmatory diagnostic sample was taken 
and further grouped into month and season of diagnosis. To assess the seasonality of 
DM diagnosis, the month and season of the first recorded consultation for controls 
was used as a comparison group to account for any seasonal variation in veterinary 
consultations. Neuter status at DM diagnosis was determined for cases and the most 
recent neuter status was extracted for controls. A four-category sex-neuter variable 
was created which, included “neutered” and “entire” categories for both sexes. 
Clinical notes and treatment details were reviewed to determine whether a dog was 
diagnosed with the following co-morbidities or presenting signs at any time during 
data collection: hyperadrenocorticism, hypothyroidism, pancreatitis, exocrine 
pancreatic insufficiency, being overweight, haematuria and urinary tract infection. 
Dogs without these observations recorded were assumed to not have these disorders 
or abnormalities. Data were checked and cleaned in a spreadsheet (Microsoft Office 
Excel 2007, Microsoft Corp.) and exported to Stata 12.1 for further analysis (Stata 
Corp.). 
 
Descriptive statistics were generated for the incident cases and non-diabetic control 
dogs to characterise the study population. Univariable logistic regression models were 
used to evaluate associations between each individual explanatory variable (potential 
risk factor) and being diagnosed with DM. Multivariable logistic regression models 
were used to identify demographic variables that had a statistically significant 
association  (P-value ≤0.05) with DM after accounting for any confounding effects of 
other measured factors. Pairwise interactions between final model variables were 
assessed. Age was forced into the model to account for the frequency matching in the 
sampling strategy. “Clinic ID”  was included as a random effect to assess for 
clustering at the practice level (Dohoo and others 2009). Co-morbidities and 
presenting signs were individually added to the multivariable logistic regression 
model to measure the associations of these variables with DM after adjusted for 
potential confounding effects of the other variables. Model fit was assessed with the 
Hosmer-Lemeshow test (Hosmer and Lemeshow 2000). Breed and the effect of sex 
and neuter status were of a-priori interest. 
 
Survival analysis 
 
For the survival analysis, the censoring status of incident DM cases was determined 
on the date of death (uncensored, all-cause mortality), the date that animals left the 
participating clinic (censored) or the last date of the study period (censored). The 
median survival time was defined as the time following DM diagnosis when the 
cumulative proportion of dogs surviving fell to 50% (Jager and others 2008). Clinic 
ID, breed, maximum bodyweight, sex, neuter status, insurance status and season of 
diagnosis were recorded as for the case-control study. The age at DM diagnosis was 
extracted and categorised into three groups (3.0 - <10.0 years, 10.0 - <12.0 years and 
≥12.0 years) and dogs were classified as overweight for the survival analysis if this 
was noted on or before the date of DM diagnosis. When available, the presence of 
ketonuria and pancreatitis up to 7 days before or after DM diagnosis was recorded. 
Treatment records were examined for oral or parenteral corticosteroids or 
progestagens administered within 6 weeks preceding DM diagnosis. A time restriction 
was not applied to dogs with hyperadrenocorticism, as the date of diagnosis may be 
less likely to reflect onset of the disease; to avoid false positive results due to the 
physiological stress response to diabetes (Gilor and Graves 2011), adrenal function 
tests may be delayed in unstable diabetic patients.  
 Univariable and multivariable Cox regression models were used to assess whether 
each explanatory variable was associated with survival in diabetic dogs; both 
individually and after adjusting for the confounding effects of other variables 
respectively. Hazard ratios (HR) indicate whether the “hazard of death” is increased 
or decreased in dogs within different categories in a variable. Statistical significance 
was set at the 5% level. Evaluation of confounding and interaction were performed as 
for logistic regression. Including “clinic ID” as a frailty term assessed for clustering at 
the practice level. The proportional hazards assumption (that the HR is constant over 
time) was checked by statistical assessment using Schoenfeld residuals and graphical 
assessment of log cumulative hazard and Kaplan-Meier Cox plots (Dohoo and others 
2009).  
Results 
Descriptive statistics and prevalence estimate  
 
Data were available from 128,210 dogs attending 89 primary practice clinics, located 
mostly in central and south-east England. Four hundred and thirty-nine dogs 
diagnosed with DM were identified within the EPRs, giving an apparent prevalence of 
0.34% (95%CI: 0.31-0.37%). Two hundred and nine diabetic dogs (47.6%) were 
incident cases (newly diagnosed with DM during the data collection period). Further 
analyses relate only to the incident cases. The median age of onset of DM was 9.9 
years (range 3.3 – 17.4 years). There were 105 female and 104 male diabetic patients, 
of which 68 (64.8%) and 81 (77.9%) respectively were neutered at the time of DM 
diagnosis. A slightly higher proportion of female controls (68.5%) and a lower 
proportion of male controls (58.3%) were neutered compared to the diabetic patients. 
Most diabetic patients (70.4%) had a maximum weight of less than 20kg during the 
study period and 83.2% were purebred dogs. Twenty-four diabetic dogs (11.5%) were 
diagnosed with pancreatitis, two-thirds of which were diagnosed with DM and 
pancreatitis concurrently. Eighteen (8.6%) diabetic dogs were diagnosed with 
hyperadrenocorticism, either prior to or during the study period. No dogs were 
diagnosed with exocrine pancreatic insufficiency.  
Case-control study 
Although there was no evidence of an overall association between sex and a diagnosis 
of DM in univariable analysis (P = 0.572, Table 1), the combined sex-neuter variable 
was significantly associated with the odds of DM (P = 0.004). Entire males had lower 
odds of DM compared with neutered males and females. Neutered males had 
approximately 2.5 times the odds of DM compared with entire males (OR 2.52, 95%CI: 
1.48 – 4.31) and a significant difference between neutered and entire females was not 
detected (OR 0.85, 95%CI: 0.51 – 1.39, P = 0.510). There were strong associations 
between both weight and breed and DM in univariable analysis. Lighter dogs were 
more likely to be diagnosed with DM than heavier dogs (P <0.001). Similarly, 
compared with crossbred dogs, small breeds tended to have higher odds, whereas large 
breeds generally had lower odds of DM (Table 1). There was no statistically significant 
association between DM diagnosis and insurance status, whether a dog was purebred or 
crossbred overall or whether a dog was of a UK Kennel Club recognised breed. 
Although there was a trend towards an association between season of diagnosis and 
DM in univariable analysis, with lower proportions of dogs being diagnosed with DM 
in summer and autumn compared with winter and spring, the association failed to be 
significant (P = 0.080). There were strong associations between all of the selected co-
morbidities and DM in univariable analyses, with the exception of hypothyroidism. 
 
The multivariable logistic regression model contained observations for 627 animals 
and included the following variables: sex stratified by neuter status, the individual 
breed variable and age group (Table 2). Neutered males had more than twice the odds 
of a diagnosis of DM compared to entire males (OR 2.26, 95%CI: 1.29-3.96). 
Yorkshire terriers (OR 4.56, 95%CI: 1.79-11.64) had the highest odds of DM. 
Conversely, golden retrievers had 0.12 (95%CI: 0.02-0.96) times the odds and 
German shepherd dogs had 0.06 (95%CI: 0.00-1.00) times the odds of DM compared 
with crossbreds. The Hosmer-Lemeshow test indicated good model fit (P = 0.921). 
Clustering was not significant when “clinic ID” was included as a random effect (P = 
0.339).  
 
When added individually to the multivariable model, there were strong associations 
between DM diagnosis and being diagnosed with pancreatitis (OR 13.03, 95%CI: 
4.25 - 39.94, P < 0.001), hyperadrenocorticism (OR 20.35, 95%CI: 4.45 - 93.20, P < 
0.001), having a urinary tract infection (OR 5.35, 95%CI: 1.97 – 14.54, P = 0.001) 
and haematuria detected (OR 14.48, 95%CI: 6.91 – 33.85, P < 0.001) (Table 3). 
Being recorded as overweight within EPRs was associated with a diagnosis of DM 
(OR 3.26, 95%CI: 1.93 – 5.50, P < 0.001).   
Survival analysis 
There were 91 deaths (43.5%) from all-cause mortality during the study period, with 
most deaths occurring shortly after DM diagnosis (Figure 1). The median survival 
time was 17.3 months after DM diagnosis. Diabetic dogs that were insured, neutered 
and Kennel Club recognized breeds had lower hazards of death (longer survival 
times) in the univariable analysis. Dogs that were older and those diagnosed with 
pancreatitis and ketonuria at the time of DM diagnosis had increased hazards of death. 
There was a weak association between individual breeds and hazard of death in 
univariable analysis. There was insufficient evidence of survival differences 
associated with sex, weight, purebred status, season of DM diagnosis, 
hyperadrenocorticism, being overweight and prior glucocorticoid treatment in 
univariable analysis (Table 4). 
  
Insurance status, neuter status, pancreatitis and age group remained statistically 
significant in the multivariable Cox model. Insured dogs had a hazard ratio of 0.60 
(95%CI: 0.38-0.94, P = 0.023) compared with uninsured dogs. Dogs recorded as 
being neutered at the time of DM diagnosis had a hazard ratio of 0.56 (95%CI: 0.36-
0.88, P = 0.014) compared with entire dogs. Dogs with a diagnosis of pancreatitis had 
a hazard ratio of 2.51 (95%CI 1.28-4.95, P = 0.016) compared with those without. 
Dogs aged 10 to less than 12 years had a hazard ratio of 1.38 (95%CI: 0.85-2.25) and 
dogs aged 12 years and above had a hazard ratio of 2.16 (95%CI: 1.28-3.63) 
compared to dogs aged 3 to less than 10 years old (Table 5). Breed and the presence 
of ketonuria were evaluated but not retained in the final multivariable Cox model. 
There was no evidence that the proportional hazards assumption was violated in the 
final model. Including clinic as a frailty term did not improve model fit (P = 0.499). 
Discussion   
The current study identified a prevalence of DM of 0.34% (95%CI: 0.31-0.37%) for 
dogs presenting to a large group of primary practices. Certain breeds and being 
neutered (in males) were factors associated with a diagnosis of DM. Diagnoses of 
pancreatitis, hyperadrenocorticism, urinary tract abnormalities, and being overweight 
were also associated with DM. Overall, median survival time was 17.3 months 
following DM diagnosis, although increasing age and a concurrent diagnosis of 
pancreatitis were associated with an increased hazard, whereas insured and neutered 
dogs had a decreased hazard of death.  
 
The apparent prevalence of 0.34% (95%CI: 0.31-0.37%) is lower than the estimates 
reported by studies using referral populations in other countries (0.64% (Guptill and 
others 2003) and 1.33% (Fracassi and others 2004)). These differences may have 
resulted from selection bias or temporal, geographical or other population differences. 
However, the prevalence estimate in the present study is similar to that previously 
reported in a population of insured dogs in UK (0.32%) (Davison and others 2005). 
Further, the current study found no association between being insured and being 
diagnosed with DM, suggesting that both primary care and insurance data may be 
appropriate sources for estimating DM prevalence.  
 
There was no evidence for a female predisposition to DM, as observed in another UK 
study (Davison and others 2005) but in contrast with other research (Foster 1975; 
Doxey and others 1985; Guptill and others 2003; Fall and others 2007). It has been 
suggested that the proportion of diabetics of each sex in study populations may be 
influenced by differences in neutering practices, as entire females may develop 
progesterone-induced DM (Fall and others 2010). However, neuter status did not have 
a significant effect on the odds of female dogs developing DM in the current study. It 
is possible that the lack of an association may result from confounding by obesity as 
neutered females had approximately twice the odds of being overweight than entire 
females (OR 2.15, 95%CI: 1.00-4.67, P = 0.040) in the case-control population. The 
increased risk of being overweight in neutered females and the subsequent likely 
impact of this on the odds of DM may counteract any increased risk in entire females 
due to progesterone effects. In male dogs the association was different, with neutered 
males being at increased odds of DM compared to entire males. One possible 
explanation is that male-sex hormones may have a protective effect against DM, 
although other factors associated with neutering in males may also influence this 
association. The interaction between neutering and sex on the effect of DM diagnosis 
identified here is consistent with a pattern reported in a population of dogs attending 
teaching hospitals in the USA (Guptill and others 2003).  
 
Consistent with other studies (Hess and others 2000a; Guptill and others 2003; 
Fracassi and others 2004; Catchpole and others 2005), specific breeds were associated 
with DM in the current study, although our study lacked the power to detect 
differences between all but the most common breeds. These breed predispositions 
suggest that genetic components influence the susceptibility of some individuals to 
canine DM (Catchpole and others 2013). In addition, a strong association between 
bodyweight and DM diagnosis was identified in univariable analysis in the current 
study; with lighter dogs having higher odds of DM compared to heavier dogs. This 
may relate to the individual breeds associated with a diagnosis of DM. Further, all of 
the dogs diagnosed with hyperadrenocorticism, a potential risk factor for DM, were 
less than 20 kg, which may be breed-related. A non-significant trend towards lighter 
dogs being associated with older age was also identified (P = 0.141). Although age 
group was included in the multivariable model, residual confounding is possible; if 
small breeds tend to live longer, they may be more likely to develop diseases 
afflicting geriatric animals, such as DM. 
 
Being recorded as being overweight was associated with a diagnosis of DM, although 
weight classification was subjective and under-reporting was likely. Diabetic dogs 
may be more likely to be examined regularly and concerns regarding their weight may 
be more likely to be recorded. Consistent with other studies, being diagnosed with 
hyperadrenocorticism and pancreatitis were associated with DM (Hess and others 
2000b; Davison and others 2005; Hume and others 2006; Blois and others 2011). 
Hyperadrenocorticism increases gluconeogenesis and can cause insulin resistance 
(Gilor and Graves 2011) and pancreatitis has been proposed to cause DM by 
damaging insulin-producing beta cells (Watson and others 2007). It is biologically 
plausible that these disorders preceded DM; although temporality could not be 
assessed in the case-control study and reverse causality could not be ruled out.  
 
A strong association between being diagnosed with urinary tract abnormalities and 
DM was also identified.  However, a causal relationship has not been established and 
urinary tract abnormalities are likely to be secondary to DM (Hess and others 2000b). 
In combination with other tools, urinalysis can be used to manage diabetic patients 
(Cook 2012). Urinary abnormalities may therefore be more likely to be detected in 
diabetic patients than non-diabetic dogs, biasing this result.  
 
In the current study, median survival time was 17.3 months following diagnosis of 
DM. This was longer than the median survival time of 57 days reported for a 
population of insured diabetic dogs in Sweden (Fall and others 2007). This 
discrepancy may have been partly due to the popularity of hunting breeds in the 
Swedish population, which had lower survival rates than other breeds (Fall and others 
2007). 
 
Dogs diagnosed with pancreatitis within 7 days of DM diagnosis had an increased 
hazard of death. This finding contrasts with those of Hume and others (2006), who 
found an association between mortality and hyperadrenocorticism, but not 
pancreatitis, in a study of dogs with DKA. However, because these studies had 
different case definitions, methodology, veterinary facilities and geographical 
locations, they are not directly comparable.  
 
Although being insured was not associated with DM diagnosis, it was associated with 
increased survival following diagnosis. This may reflect that DM is a low-cost 
condition to diagnose, whereas longer-term management requires a considerable 
financial and emotional commitment. Improved survival in diabetic dogs that are 
insured may result from inherent characteristics specific to owners who choose to 
insure, combined with reduced financial restrictions to potentially lengthy and 
expensive treatment protocols.  This finding also suggests that using insurance data to 
evaluate survival may result in biased results and that primary practice data, that 
includes both insured and uninsured dogs, should better reflects the survival of the 
wider dog population. Overall, neutered diabetic patients had a hazard ratio of 0.56 
(95%CI: 0.36-0.88) compared to entire animals. This survival difference may reflect 
either a biological advantage (due to low concentrations of sex steroids) or may be a 
proxy for owners who are more likely to treat and less likely to euthanase their pets.  
 
There were some limitations to the current study. The data analysed were not 
primarily recorded for research purposes, so may have contained inconsistencies and 
errors. Veterinary surgeons were not blinded to the health status of dogs, so diabetic 
patients may have been more likely to undergo testing for co-morbidities. Similarly, 
dogs with other chronic diseases may have been more likely to be diagnosed as DM 
cases if they had been investigated more intensively than otherwise healthy dogs. It 
was not possible to ascertain dietary intake or exercise, which could confound the 
associations between DM and other variables. Finally, charity, mixed or non-
corporate veterinary clinics may differ from this population of corporate owned 
companion animal clinics.  
 
In conclusion, awareness of the associations between neutered males, specific breeds 
and diagnoses of pancreatitis or hyperadrenocorticism and DM could aid clinicians 
when considering DM as a differential diagnosis. Older dogs or those with 
pancreatitis at DM diagnosis may have a less favourable prognosis, whilst insured and 
neutered diabetics appeared to have a reduced hazard of death. On-going data 
collection within the VetCompass project will enable larger analyses of affected 
animals in subsequent years to generate epidemiological trends over time. This may 
be of particular value as clinical management evolves and new treatments for this 
complex, multifactorial disorder are introduced.  
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Table 1: Descriptive statistics and univariable logistic regression analysis results for 
risk factors associated with canine diabetes mellitus in a case-control study nested 
within a population of 128,210 dogs attending primary practices in England.  
Variable Case (%) Control 
(%) 
OR
1
 95% CI
2
 P-value 
Sex 
Female 105 (50.2) 200 (47.9) Base 0.572 
Male 104 (49.8) 218 (52.1) 0.91 (0.65 – 1.27) 
Neuter status 
Entire 60 (28.7) 154 (36.8) Base 0.041 
Neutered 149 (71.3) 264 (63.2) 1.45 (1.01 – 2.07) 
Sex-neuter      
Male-entire 23 (11.0) 91 (21.8) Base  0.004 
Male-neuter 81 (38.8) 127 (30.4) 2.52 (1.48 – 4.31) 
Female-entire 37 (17.7) 63 (15.1) 2.32 (1.26 – 4.28) 
Female-neuter 68 (32.5) 137 (32.8) 1.96 (1.14 – 3.38) 
Insurance status  
Not insured 122 (60.1) 245 (62.7) Base 0.543 
Insured 81 (39.9) 146 (37.3) 1.11  (0.79 – 1.58) 
Maximum weight (kg) during study period 
Below 10.0 63 (32.1) 75 (22.0) Base <0.001 
 10.0 to less than 20.0 75 (38.3) 89 (26.1) 0.67 (0.56 – 0.79) 
20.0 to less than 30.0 31 (15.8) 79 (23.2)   
30.0 and above 27 (13.8) 98 (28.7)   
Purebred status 
Crossbred 35 (16.8) 76 (18.2) Base 0.656 
Purebred 174 (83.2) 342 (81.8) 1.10  (0.71 – 1.72) 
UK Kennel Club recognised breed 
No 60 (28.7) 121 (29.0) Base 0.950 
Yes 149 (71.3) 297 (71.0) 1.01 (0.70 – 1.46) 
Season DM diagnosed (cases) or season of first veterinary consultation (controls) 
Winter  55 (26.3) 98 (23.4) 1.58 (0.97 – 2.59) 0.080 
Spring 65 (31.1) 101 (24.2) 1.82 (1.12 – 2.93) 
Summer 39 (18.7) 110 (26.3) Base  
Autumn 50 (23.9) 109 (26.1) 1.29 (0.79 – 2.12) 
Breed (≥10 dogs)          
Yorkshire terrier 18 (8.6) 8 (1.9) 4.77 (1.88 – 
12.10) 
<0.001 
Border terrier 6 (2.9) 4 (1.0) 3.18  (0.84 – 
12.04) 
Bichon frise 7 (3.4) 6 (1.4) 2.47 (0.77 – 7.94) 
CKCS
3
 9 (4.3) 8 (1.9) 2.39 (0.84 – 6.74) 
Border collie 11 (5.3) 11 (2.6) 2.12 (0.83 – 5.39) 
WHWT
4
 16 (7.7) 19 (4.6) 1.79 (0.82 – 3.91) 
Cocker spaniel 9 (4.3) 13 (3.1) 1.47 (0.57 – 3.78) 
Jack Russell terrier 24 (11.5) 44 (10.5) 1.16 (0.61 – 2.21) 
Crossbred 33 (15.8) 70 (16.8) Base  
Purebred others 60 (28.7) 117 (28.0) 1.09 (0.65 – 1.83) 
Labrador retriever 11 (5.26) 48 (11.5) 0.49 (0.22 – 1.06) 
Staffordshire bull 
terrier 
3 (1.44) 22 (5.3) 0.29 (0.08 – 1.03) 
Greyhound 1 (0.5) 11 (2.6) 0.19 (0.02 – 1.56) 
German shepherd 
dog
5
 
0 (0) 18 (4.3) 0.06 (0.00 – 0.97) 
Golden retriever 1 (0.5) 19 (4.6) 0.11 (0.01 – 0.87) 
Co-morbidities and presenting signs  
Overweight  No 165 (78.9) 382 (91.4) Base  
<0.001 Ye
s 
44 (21.1) 36 (8.6) 2.83 (1.76 – 4.56) 
Pancreatitis No 185 (88.5) 414 (99.0) Base  <0.001 
Ye
s 
24 (11.5) 4 (1.0) 13.43 (4.59 – 
39.25) 
Hyperadrenocor
ticism 
No 191 (91.4) 416 (99.5) Base  <0.001 
Ye
s 
18 (8.6) 2 (0.5) 19.60 (4.50 – 85-
33) 
Hypothyroidism No 207 (99.0) 412 (98.6) Base  0.606 
Ye
s 
2 (1.0) 6 (1.4) 0.66 (0.13 – 3.32) 
Haematuria No 165 (79.0) 411 (98.3) Base  <0.001 
Ye
s 
44 (21.0) 7 (1.7) 15.66 (6.91 – 
35.47) 
Urinary tract 
infection 
No 193 (92.3) 411 (98.3) Base  <0.001 
Ye
s 
16 (7.7) 7 (1.7) 4.87 (1.97 – 
12.03) 
Age group (frequency matched)    
3.0 to less than 8.0 years 41 
(19.6) 
82 (19.6)   1.000 
8.0 to less than 11.0 years 85 
(40.7) 
170 (40.7) 1 (0.63 – 1.58) 
11.0 to less than 13.0 
years 
57 
(27.3) 
114 (27.3) 1 (0.61 – 1.63) 
13.0  years and above 26 
(12.4) 
52 (12.4) 1 (0.55 – 1.82) 
1
OR = Odds ratio
 
2
95% CI = 95% confidence interval 
3
Cavalier King Charles spaniel
 
4
West Highland white terrier 
5
Values for German shepherd dog were derived by firth logit due to complete 
separation 
 
  
Table 2: Multivariable logistic regression analysis results for risk factors associated 
with canine diabetes mellitus in a case-control study nested within a population of 
128,210 dogs attending primary practices in England. Observations for 627 
individuals. 
Variable OR
1
 95% CI
2
 P-value 
Sex-neuter    
Male-entire Base  0.031 
Male-neuter 2.26  (1.29 – 3.96) 
Female-entire 2.00 (1.05 – 3.82) 
Female-neuter 1.81 (1.03 – 3.18) 
Breed (≥10 dogs)   
Yorkshire terrier 4.56 (1.79 – 11.64) <0.001 
Border terrier 3.49 (0.91 – 13.42) 
CKCS
3
 2.54 (0.88 – 7.29) 
Bichon frise 2.27 (0.70 – 7.35) 
Border collie 2.22 (0.87 – 5.72) 
WHWT
4
 1.99 (0.89 – 4.42) 
Cocker spaniel 1.48 (0.57 – 3.83) 
Jack Russell terrier 1.17 (0.61 – 2.26) 
Crossbred Base  
Purebred others 1.14 (0.68 – 1.93) 
Labrador retriever 0.54 (0.25 – 1.18) 
Staffordshire bull terrier 0.31 (0.09 – 1.13) 
Greyhound 0.20 (0.02 – 1.63) 
Golden retriever 0.12 (0.02 – 0.96) 
German shepherd dog
5
 0.06 (0.00 – 1.00) 
Age group (frequency matched)   
3.0 to less than 8.0 years Base  0.984 
 8.0 to less than 11.0 years 0.96 (0.59 – 1.55) 
11.0 to less than 13.0 years 1.04 (0.62 – 1.76) 
13.0 years and above 0.99 (0.53 – 1.85) 
1
OR = Odds ratio
 
2
95% CI = 95% confidence interval 
3
Cavalier King Charles spaniel
 
4
West Highland white terrier 
5
Values for German shepherd dog were derived by firth logit due to complete 
separation 
  
Table 3: Co-morbidities and presenting signs individually added to final multivariable 
logistic regression model for risk factors associated with canine diabetes mellitus in a 
nested case-control study from a population of 128,210 dogs attending primary 
practices in England. 
Co-morbidity or  
presenting sign 
OR
1
 95% CI
2
 P-value 
Overweight  No Base  <0.001 
Yes 3.26 (1.93 – 5.50) 
Pancreatitis No Base  <0.001 
Yes 13.03 (4.25 – 39.94) 
Hyperadrenocorticism No Base  <0.001 
Yes 20.35 (4.45 – 93.20) 
Hypothyroidism No Base  0.773 
Yes 1.29 (0.23 – 7.22) 
Haematuria No Base  <0.001 
Yes 14.48 (6.91 – 33.85) 
Urinary tract infection No Base  0.001 
Yes 5.35 (1.97 – 14.54) 
1
OR = Odds ratio
 
2
95% CI = 95% confidence interval 
 
  
Table 4: Descriptive statistics and univariable Cox regression analysis of risk factors 
associated with survival in a population of 209 dogs diagnosed with diabetes mellitus 
in primary practice in England 
Variable  Number (%) HR
1
 95% CI
2
 P-
value 
Insurance status   
Not insured 131 (62.7) Base 0.007 
Insured 78 (37.3) 0.54 0.35 - 0.86 
Sex  
Female 105 (50.2) Base 0.716 
Male 104 (49.8) 0.93 0.61 – 1.40 
Neuter status  
Entire 60 (28.7) Base 0.043 
Neutered 149 (71.3) 0.64 0.41 – 0.98 
Sex-Neuter     
Male-entire 23 (11.0) Base  0.140 
Male-neuter 81 (38.8) 0.47 0.25 – 0.89 
Female-entire 37 (17.7) 0.70 0.35 – 1.41 
Female-neuter 68 (32.5) 0.57 0.30 - 1.07 
Age group (years)  
3.0 to less than 10.0 108 (51.7) Base 0.013 
10.0 to less than 12.0 64 (30.6) 1.40 0.89 – 2.34 
12.0 and above 37 (17.7) 2.20 1.32 – 3.67 
Maximum weight (kg)  
Below 10.0 63 (32.1) Base 0.460 
10.0 to less than 20.0 75 (38.3) 0.94 0.56 – 1.58 
20.0 to less than 30.0 31 (15.8) 0.62 0.29 – 1.32 
30.0 and above 27 (13.8) 1.18 0.62 –2.27 
Purebred status  
Crossbred 35 (16.8) Base 0.389 
Purebred 174 (83.2) 0.79 0.47 – 1.33 
Kennel club registered breed  
No 60 (28.7) Base 0.050 
Yes 149 (71.3) 0.65 0.42 – 0.99 
Season diabetes mellitus diagnosed  
Winter 55 (26.3) 0.97  0.51 – 1.84 0.894 
Spring 65 (31.1) 1.19 0.65 – 2.16 
Summer 39 (18.7) Base  
Autumn 50 (23.9) 1.10 0.59 – 2.06 
Breed ≥10 dogs  
Jack Russell terrier 24 (11.5) 1.51 0.75 – 3.16 0.081 
Labrador retriever 11 (5.3) 1.23 0.48 – 3.24 
Crossbred  33 (15.8) Base  
Yorkshire terrier 18 (8.6) 0.88 0.38 – 2.05 
Purebred other 96 (45.9) 0.87 0.49 – 1.55 
West Highland white terrier 16 (7.7) 0.35 0.10 – 1.22 
Border collie 11 (5.3) 0.30 0.07 – 1.32 
Co-morbidities and presenting signs 
Ketonuria No 69 (46.0) Base 0.053 
Yes 81 (54.0) 1.66 0.99 – 2.78 
Pancreatitis No 193 (92.3) Base   0.022 
Yes 16 (7.7) 2.36 1.22 – 4.59 
Hyperadreno
- 
Corticism 
No 191 (91.4) Base 0.994 
Yes 18 (8.6) 1.00 0.48 – 2.06 
Overweight  No 171 (81.8) Base 0.722 
Yes 38 (18.2) 1.10 0.65 – 1.87 
Prior 
glucocorticoi
d treatment 
No 187 (89.5) Base 0.362 
Yes 22 (10.5) 1.36 0.72 – 2.55 
1
HR = Hazard ratio
 
2
95% CI = 95% confidence interval 
 
 
  
Table 5: Final multivariable Cox regression model for risk factors associated with 
survival in a population of 209 dogs diagnosed with diabetes mellitus in primary 
practice in England 
Variable HR
1
 95% CI
2
 P-value 
Pancreatitis No Base 0.016 
 Yes 2.51 1.28- 4.95 
Age group 
(years) 
3.0 to less than 10.0 Base 0.019 
 10 to less than 12.0 1.38 0.85 – 2.25 
12.0 and above 2.16 1.28 – 3.63 
Insured No Base 0.023 
 Yes 0.60 0.38 - 0.94 
Neutered No Base 0.014 
Yes 0.56 0.36 - 0.88 
1
HR = Hazard ratio
 
2
95% CI = 95% confidence interval 
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